Neoantigen cancer vaccines: a new star on the horizon
Immunotherapy represents a promising strategy for cancer treatment that utilizes immune cells or drugs to activate the patient’s own immune system and eliminate cancer cells. One of the most exciting advances within this field is the targeting of neoantigens, which are peptides derived from non-syno...
Main Authors: | Xiaoling Li, Jian You, Liping Hong, Weijiang Liu, Peng Guo, Xishan Hao |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2024-04-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/21/4/274 |
Similar Items
-
Mutation-Derived Neoantigens for Cancer Immunotherapy
by: John C. Castle, et al.
Published: (2019-08-01) -
Computational Prediction and Validation of Tumor-Associated Neoantigens
by: Vladimir Roudko, et al.
Published: (2020-01-01) -
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
by: Jiangping Li, et al.
Published: (2023-08-01) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023-12-01) -
T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
by: Malcolm J. W. Sim, et al.
Published: (2022-02-01)